Production (Stage)
BetterLife Pharma Inc.
BETR
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.39% | -19.36% | -82.50% | 23.81% | 31.47% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -150.94% | 679.68% | 285.56% | -33.43% | -40.54% |
| Change in Net Operating Assets | 213.31% | 105.79% | -106.65% | -53.90% | -26.40% |
| Cash from Operations | 41.30% | 19.05% | 5.07% | 4.47% | 20.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | 308.07% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.29% | -67.50% | -69.26% | -56.37% | -69.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | 59.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -51.21% | -96.71% |
| Cash from Financing | -64.54% | -20.89% | -9.75% | -3.27% | -20.53% |
| Foreign Exchange rate Adjustments | -- | -- | -103.85% | -100.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -332.99% | -197.40% | -247.46% | 53.07% | -26.51% |